通过观察细胞病变效应，用噻唑蓝(MTT)比色法检测细胞存活率，以确定该药物治疗指数。
By means of observing cytopathic effect and adopting MTT colorimetric assay for cell survival rate, their therapeutic index was calculated.
1在流行国家采购的抗疟治疗药品方面存在指数增长：从2004年采购的400万以青蒿素为基础的联合治疗药物增至2005年3000多万。
There has been an exponential increase in anti-malarial treatments procured by endemic countries: from 4 million ACTs procured in 2004 to more than 30 million in 2005.
亚标准包括儿童的皮肤病生活质量指数(CDLQI)，金黄色葡萄球菌在皮肤的分布情况和皮肤的药物治疗情况。
Secondary measures included the Children's Dermatology Life Quality Index (CDLQI), S. aureus skin colonization, and pharmacological skin treatment.
应用推荐